Initial Designation. The Directors designated as of the Effective Date are set forth on Schedule 4.6 hereto.
Appears in 2 contracts
Sources: Limited Liability Company Agreement (Isis Pharmaceuticals Inc), Limited Liability Company Agreement (Alnylam Pharmaceuticals, Inc.)